Urological cancer, Malmö
11 – 20 of 543
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study
2025) In European Urology Oncology(
- Contribution to journal › Article
-
Mark
Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer
2025) In JCO Oncology Practice(
- Contribution to journal › Article
-
Mark
Convalescence after radical orchiectomy : Detailing surgical recovery with a novel electronic patient reported outcome (ePRO) platform
(
- Contribution to journal › Article
-
Mark
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2) : Results from an International Multicentre Registry Study
2025) In European Urology(
- Contribution to journal › Article
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2025 Update
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Confirmatory Biopsy Outcomes in Patients with Grade Group 2 Prostate Cancer : Implications for Early Management
(
- Contribution to journal › Article
-
Mark
Human proteome distribution atlas for tissue-specific plasma proteome dynamics
(
- Contribution to journal › Article
-
Mark
Outcome prediction of prostate cancer patients on active surveillance using weakly supervised deep learning
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model
(
- Contribution to journal › Article